300 articles from
- Advice
- AI in Practice
- Alternatives
- Analysis
- Asia in Focus
- Asset Allocation
- Clients
- Comings and Goings
- Commercial Property
- Compliance
- Daily Market Update
- Defensive Assets
- ETF
- Fintech
- Funds in Focus
- Growth Assets
- INDepth
- Industrial
- Industry Governance
- Industry Profiles
- Infrastructure
- Insurance and Risk
- Intergen Wealth Transfer
- Investment
- Networking / Social
- Operations
- Portfolio Construction Strategy
- Practice Growth
- Purchase, Merger Sale Of Practice
- Real Assets
- Reporting Season
- SMSF
- Succession Planning
- Superannuation
- Tax
- Teams
- Technology
- USA In Focus
- Young Professionals
Thinking forward: Three ASX biotech stars
And still they keep coming – here’s the fourth instalment of our series on the fascinating ASX cohort of medical device developers. As always,...
Spatium's secret small cap sauce
Four years ago, old high-school buddies Nicholas Quinn and Jesse Moors were taking in the sunshine at a café on Melbourne’s Southbank, when they...
Will $5.20 Fill the Missing Link?
Shareholders of Link Administration Holdings (LNK), which provides services to the funds management and superannuation sectors and runs the share registry for...
Battleground: BHP vs RIO
Big Australian Wins Battle of the Bulks OK, so you want to own a big global diversified bulk miner, to take advantage of the impending commodities boom –...
Thinking ahead - ASX MedTech leaders
Here’s the fourth instalment of our series on the fascinating ASX cohort of medical device developers. ImpediMed (IPD, 8.1 cents)Market capitalisation:...
Riding for charity with Invesco
Like everyone, Eben Bowditch, head of sales at Invesco Australia, was trying to navigate the abnormal and difficult times of the COVID-19 pandemic and...
Playing Tesla's battery day via ETFs
One of the great investment success stories of the last 25 years has been the exchange-traded fund (ETF), which got under way in the early 1990s as a vehicle...
Lendi Listing Looks for Loan Liftoff
Another fintech is heading for the ASX screens, with online mortgage provider Lendi poised to push “go” on an initial public offering (IPO) that...
Device Stars Part 3
4DMedical (4DX, $1.58)Market capitalisation: $418 millionThree-year total return: n/aAnalysts’ consensus target price: $1.70 (Thomson Reuters) Imaging...
Backing Buffett's Big Japan Bet
It seems as if Japan does not get a lot of respect from external investors, for good reasons. The Nikkei index appears to disprove the theory that the...
Semi-Loved and Semi-Understood - but Semiconductors Rule
Semiconductors would have to be one of the most pervasive and critical pieces of technology in our daily lives – but they are usually not thought about...
Get to know Troy Armstrong from Koda Capital
Troy is a Partner and Adviser at Koda Capital. Troy is a FASEA-compliant financial adviser holding a Bachelor of Commerce and SMSF Specialist Adviser...
Look to Your Own Devices: Biotech Stars of the ASX
In the first of a series on Australian biotech success stories, we start with some of the outstanding medical device stocks on the ASX.
Earnings Season is Here - and It's Going to be Ugly
With July coming to a close, it's time for reporting season - and this year, it's not going to be pretty.
Latin American E-Commerce Giant Worth a Long Look
While more and more Australian investors get comfortable with investing overseas, it's fair to assume that Latin America is not on most people's map of the...